Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs
Bullboard Posts
User Avatar Image
(163)
•••
Comment by Sniper007on Nov 25, 2016 10:06pm
102 Views
Post# 25516199

RE:RE:RE:RE:RE:well well well

RE:RE:RE:RE:RE:well well well
beenthere, I'm p*ssed because you think you're right and keep whining about that and everything else biOasis. You're not right (ain't that the truth), not yet, so shut your trap until Dec.31. The game's not over, butt, like regardless, you act as though it is, even though I admit the chances are becoming less as each day passes that the sp will skyrocket to $20 (my apparent overly optimistic guess). You're just trash talking and nobody likes that. However, if your guess at the end of the year, is closest, you have my permission to gloat and trash talk for a maximum of two posts! And if you win, I promise to congratulate you! Until that time I would kindly ask you and regardless to refrain from bashing the company so routinely... bwaahahaha!!!... and that's the joke of the day!!! 'Tis almost the season where humans become nice to one another for a time, but me, I can still be a scrooge! Sniper
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities